September 23, 2024 Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement
September 4, 2024 Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board
July 25th, 2024 Nicox Announces Recruitment of Last Patient in U.S. in Denali Phase 3 Trial of NCX 470